Pharmacotherapy of type1 diabetes in children and adolescents: more than insulin? - Wikidata - awgldk - TriplyDB

Pharmacotherapy of type1 diabetes in children and adolescents: more than insulin?

Pharmacotherapy of type1 diabetes in children and adolescents: more than insulin?

http://www.wikidata.org/entity/Q54943513

about

Pharmacotherapy of type1 diabetes in children and adolescents: more than insulin?

http://www.wikidata.org/entity/Q54943513

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Pharmacotherapy of type1 diabetes in children and adolescents: more than insulin?

@en

Pharmacotherapy of type1 diabetes in children and adolescents: more than insulin?

@nl

type

label

Pharmacotherapy of type1 diabetes in children and adolescents: more than insulin?

@en

Pharmacotherapy of type1 diabetes in children and adolescents: more than insulin?

@nl

prefLabel

Pharmacotherapy of type1 diabetes in children and adolescents: more than insulin?

@en

Pharmacotherapy of type1 diabetes in children and adolescents: more than insulin?

@nl

P1433

Q54943513-D42ABCA5-9413-4372-9213-EA6E3D0E5C73

P1476

Q54943513-B8CCA5C4-7942-427D-A3D1-2BBE76F60CE3

P2093

Q54943513-76ED11EA-F3C4-457B-A97E-A5688C5FE0B9

Q54943513-F5B87FAE-FDDA-4DB0-B925-A60E9E677B9E

P2860

Q54943513-177B3460-AEDC-4852-A509-8FC76C0DBBE2

Q54943513-2463E052-5047-4001-8AD9-E7DE15E9A9C4

Q54943513-32138C29-F6E6-4C88-A274-B1E47135C926

Q54943513-462DF197-EA43-4A48-B837-E30E74119004

Q54943513-489FF1B8-8AE0-4FCD-89DE-DC655800328E

Q54943513-550A537E-9266-4BE1-BB91-BFC015574B4C

Q54943513-5B550DF3-3E09-49C5-AA49-507F644F04E9

Q54943513-6559A72A-D8DF-47AF-B3E7-22BF778EDD7D

Q54943513-708F5C6C-1C12-4FCA-AAC7-D6A91DD4F645

Q54943513-7C64E1D9-1E14-4AD5-925B-EA1794853107

P304

Q54943513-C5618A1F-FED4-426A-A06C-F035DDB677C4

P31

Q54943513-FD4B443C-5B46-480B-827C-4C5EDCA96D4D

P356

Q54943513-9C7DAF21-9CB9-4E60-B8E2-B6F1E4DDAFE0

P433

Q54943513-5098EAC7-15CF-4CD9-857A-C12F5916CAE8

P478

Q54943513-8752540B-61D3-4851-AB7F-2E5F57C4E2E6

P50

Q54943513-B3DEF093-F4F1-40A4-8CA4-D50ABDC63673

P577

Q54943513-F90CBF3C-F56E-4E3F-9F83-350623AF380F

P698

Q54943513-7DE337AA-6CFE-496D-8671-05D82656EDA3

P921

Q54943513-8B274039-B276-485D-8DA9-FFE0A3FCBC17

Q54943513-F7C7A27F-BB22-45B7-ACD0-8EAD6C086A40

P932

Q54943513-7D113E40-1459-4C0E-A2D5-E7A24E7FF871

P356

2042018818763247

P1433

Therapeutic advances in endocrinology and metabolism

P1476

Pharmacotherapy of type1 diabetes in children and adolescents: more than insulin?

@en

P2093

Olga Kordonouri

http://www.w3.org/2001/XMLSchema#string

Thomas Danne

http://www.w3.org/2001/XMLSchema#string

P2860

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.

Insulin degludec in combination with bolus insulin aspart is safe and effective in children and adolescents with type 1 diabetes.

The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial.

Improved Postprandial Glycemic Control with Faster-Acting Insulin Aspart in Patients with Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion.

"Let the Algorithm Do the Work": Reduction of Hypoglycemia Using Sensor-Augmented Pump Therapy with Predictive Insulin Suspension (SmartGuard) in Pediatric Type 1 Diabetes Patients.

A Pooled Analysis of Clinical Pharmacology Trials Investigating the Pharmacokinetic and Pharmacodynamic Characteristics of Fast-Acting Insulin Aspart in Adults with Type 1 Diabetes.

Ultrafast-acting insulins: state of the art

Faster-acting insulin aspart provides faster onset and greater early exposure vs insulin aspart in children and adolescents with type 1 diabetes mellitus.

Effect of Metformin Added to Insulin on Glycemic Control Among Overweight/Obese Adolescents With Type 1 Diabetes: A Randomized Clinical Trial.

Effects of Sotagliflozin Added to Insulin in Patients with Type 1 Diabetes.

P304

157-166

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/2042018818763247

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-03-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29796246

http://www.w3.org/2001/XMLSchema#string

P921

pharmacotherapy

P932

5958426

http://www.w3.org/2001/XMLSchema#string